{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:49:16Z","timestamp":1793324956573,"version":"4.5.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007195","name":"Universit\u00e0 degli Studi di Napoli Federico II","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007195","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Obes Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>The goal of the present review is to address the main adiposity-related alterations in Polycystic Ovary Syndrome (PCOS) focusing on hypothalamic-pituitary-ovarian (H-P-O) axis and to provide an overview of nutraceutical and pharmacological therapeutic strategies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>Female reproduction is a complex and delicate interplay between neuroendocrine signals involving the H-P-O axis. Elements that disrupt the balance of these interactions can lead to metabolic and reproductive disorders, such as PCOS. This disorder includes menstrual, metabolic, and biochemical abnormalities as well as hyperandrogenism, oligo-anovulatory menstrual cycles, insulin resistance, and hyperleptinemia which share an inflammatory state with other chronic diseases. Moreover, as in a self-feeding cycle, high androgen levels in PCOS lead to visceral fat deposition, resulting in insulin resistance and hyperinsulinemia, further stimulating ovarian and adrenal androgen production.<\/jats:p>\n                <jats:p>In fact, regardless of age and BMI, women with PCOS have more adipose tissue and less lean mass than healthy women. Excessive adiposity, especially visceral adiposity, is capable of affecting female reproduction through direct mechanisms compromising the luteal phase, and indirect mechanisms as metabolic alterations able to affect the function of the H-P-O axis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>The intricate crosstalk between adiposity, inflammatory status and H-P-O axis function contributes to the main adiposity-related alterations in PCOS, and alongside currently available hormonal treatments, nutraceutical and pharmacological therapeutic strategies can be exploited to treat these alterations, in order to enable a more comprehensive synergistic and tailored treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s13679-023-00531-2","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T17:02:24Z","timestamp":1704301344000},"page":"51-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Hypothalamic-Ovarian axis and Adiposity Relationship in Polycystic Ovary Syndrome: Physiopathology and Therapeutic Options for the Management of Metabolic and Inflammatory Aspects"],"prefix":"10.1007","volume":"13","author":[{"given":"Maria Serena","family":"Lonardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzia","family":"Cacciapuoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Guida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Di Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Chiurazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Damiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Menale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"issue":"1","key":"531_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12958-018-0366-6","volume":"16","author":"M Goldsammler","year":"2018","unstructured":"Goldsammler M, Merhi Z, Buyuk E. Role of hormonal and inflammatory alterations in obesity-related reproductive dysfunction at the level of the hypothalamic-pituitary-ovarian axis. Reprod Biol Endocrinol. 2018;16(1):45. https:\/\/doi.org\/10.1186\/s12958-018-0366-6.","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"531_CR2","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1210\/jcem-70-4-888","volume":"70","author":"CMD Ridder","year":"1990","unstructured":"Ridder CMD, et al. Body fat mass, body fat distribution, and plasma hormones in early puberty in females. J Clin Endocrinol Metab. 1990;70(4):888\u201393. https:\/\/doi.org\/10.1210\/jcem-70-4-888.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"531_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1071\/R98010","volume":"10","author":"RJ Norman","year":"1998","unstructured":"Norman RJ, Clark AM. Obesity and reproductive disorders: a review. Reprod Fertil Dev. 1998;10(1):55. https:\/\/doi.org\/10.1071\/R98010.","journal-title":"Reprod Fertil Dev"},{"issue":"7","key":"531_CR4","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1210\/jc.2006-2274","volume":"92","author":"A Jain","year":"2007","unstructured":"Jain A, et al. Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women. J Clin Endocrinol Metab. 2007;92(7):2468\u201373. https:\/\/doi.org\/10.1210\/jc.2006-2274.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"531_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/biomedicines7010005","volume":"7","author":"S Mikhael","year":"2019","unstructured":"Mikhael S, Punjala-Patel A, Gavrilova-Jordan L. Hypothalamic-pituitary-ovarian Axis disorders impacting female fertility. Biomedicines. 2019;7(1):5. https:\/\/doi.org\/10.3390\/biomedicines7010005.","journal-title":"Biomedicines"},{"issue":"4","key":"531_CR6","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1210\/jc.2002-021516","volume":"88","author":"CK Welt","year":"2003","unstructured":"Welt CK, Pagan YL, Smith PC, Rado KB, Hall JE. Control of follicle-stimulating hormone by estradiol and the Inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition. J Clin Endocrinol Metab. 2003;88(4):1766\u201371. https:\/\/doi.org\/10.1210\/jc.2002-021516.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"531_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2217\/17455057.4.6.583","volume":"4","author":"CD Christakou","year":"2008","unstructured":"Christakou CD, Diamanti-Kandarakis E. Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome. Womens Health. 2008;4(6):583\u201394. https:\/\/doi.org\/10.2217\/17455057.4.6.583.","journal-title":"Womens Health"},{"key":"531_CR8","doi-asserted-by":"publisher","first-page":"103628","DOI":"10.1016\/j.jri.2022.103628","volume":"151","author":"Y Zhai","year":"2022","unstructured":"\u2022\u2022 Zhai Y, Pang Y. Systemic and ovarian inflammation in women with polycystic ovary syndrome. J Reprod Immunol. 2022;151:103628. https:\/\/doi.org\/10.1016\/j.jri.2022.103628. PCOS is linked to low-grade chronic inflammation (LGCI), where local inflammation of the ovary affects ovulation and impacts on systemic inflammation. This article describes very thoroughly the molecular players of LGCI in PCOS both systemically and locally, suggesting also nutraceuticals approaches for PCOS menagment.","journal-title":"J Reprod Immunol"},{"issue":"1","key":"531_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137. https:\/\/doi.org\/10.1093\/humrep\/deh098.","journal-title":"Hum Reprod"},{"issue":"1\u20132","key":"531_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mce.2005.07.002","volume":"242","author":"HH Kim","year":"2005","unstructured":"Kim HH, DiVall SA, Deneau RM, Wolfe A. Insulin regulation of GnRH gene expression through MAP kinase signaling pathways. Mol Cell Endocrinol. 2005;242(1\u20132):42\u20139. https:\/\/doi.org\/10.1016\/j.mce.2005.07.002.","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"531_CR11","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1507\/endocrj.K09E-185","volume":"56","author":"R Tsutsumi","year":"2009","unstructured":"Tsutsumi R, Webster NJG. GnRH Pulsatility, the pituitary response and reproductive dysfunction. Endocr J. 2009;56(6):729\u201337. https:\/\/doi.org\/10.1507\/endocrj.K09E-185.","journal-title":"Endocr J"},{"key":"531_CR12","doi-asserted-by":"publisher","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020;35:100937. https:\/\/doi.org\/10.1016\/j.molmet.2020.01.001.","journal-title":"Mol Metab"},{"issue":"3","key":"531_CR13","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1210\/jc.2012-3698","volume":"98","author":"S Borruel","year":"2013","unstructured":"Borruel S, et al. Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab. 2013;98(3):1254\u201363. https:\/\/doi.org\/10.1210\/jc.2012-3698.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"531_CR14","doi-asserted-by":"publisher","first-page":"10955","DOI":"10.1038\/s41598-017-09723-y","volume":"7","author":"H Kwon","year":"2017","unstructured":"Kwon H, Kim D, Kim JS. Body fat distribution and the risk of incident metabolic syndrome: a longitudinal cohort study. Sci Rep. 2017;7(1):10955. https:\/\/doi.org\/10.1038\/s41598-017-09723-y.","journal-title":"Sci Rep"},{"issue":"3","key":"531_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.tem.2021.12.004","volume":"33","author":"X Chen","year":"2022","unstructured":"Chen X, Xiao Z, Cai Y, Huang L, Chen C. Hypothalamic mechanisms of obesity-associated disturbance of hypothalamic\u2013pituitary\u2013ovarian axis. Trends Endocrinol Metab. 2022;33(3):206\u201317. https:\/\/doi.org\/10.1016\/j.tem.2021.12.004.","journal-title":"Trends Endocrinol Metab"},{"key":"531_CR16","doi-asserted-by":"publisher","unstructured":"Purwar A, Nagpure S. Insulin resistance in polycystic ovarian syndrome. Cureus. 2022; https:\/\/doi.org\/10.7759\/cureus.30351.","DOI":"10.7759\/cureus.30351"},{"issue":"5","key":"531_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian Hyperandrogenism revisited. Endocr Rev. 2016;37(5):467\u2013520. https:\/\/doi.org\/10.1210\/er.2015-1104.","journal-title":"Endocr Rev"},{"issue":"4","key":"531_CR18","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.fertnstert.2017.01.017","volume":"107","author":"DE Broughton","year":"2017","unstructured":"Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity\u2019s impact. Fertil Steril. 2017;107(4):840\u20137. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.01.017.","journal-title":"Fertil Steril"},{"issue":"4","key":"531_CR19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cmet.2010.03.002","volume":"11","author":"JW Hill","year":"2010","unstructured":"Hill JW, et al. Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metab. 2010;11(4):286\u201397. https:\/\/doi.org\/10.1016\/j.cmet.2010.03.002.","journal-title":"Cell Metab"},{"issue":"10","key":"531_CR20","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/humrep\/deu198","volume":"29","author":"HF Escobar-Morreale","year":"2014","unstructured":"Escobar-Morreale HF, Alvarez-Blasco F, Botella-Carretero JI, Luque-Ramirez M. The striking similarities in the metabolic associations of female androgen excess and male androgen deficiency. Hum Reprod. 2014;29(10):2083\u201391. https:\/\/doi.org\/10.1093\/humrep\/deu198.","journal-title":"Hum Reprod"},{"key":"531_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/139239","volume":"2013","author":"K Makki","year":"2013","unstructured":"Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm. 2013;2013:1\u201312. https:\/\/doi.org\/10.1155\/2013\/139239.","journal-title":"ISRN Inflamm"},{"issue":"1","key":"531_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13048-021-00867-0","volume":"14","author":"Y Yang","year":"2021","unstructured":"Yang Y, Xia J, Yang Z, Wu G, Yang J. The abnormal level of HSP70 is related to Treg\/Th17 imbalance in PCOS patients. J Ovarian Res. 2021;14(1):155. https:\/\/doi.org\/10.1186\/s13048-021-00867-0.","journal-title":"J Ovarian Res"},{"key":"531_CR23","doi-asserted-by":"publisher","unstructured":"Sadeghi\u00a0A. et al. Circulating levels of C1q\/TNF-\u03b1-related protein 6 (CTRP6) in polycystic ovary syndrome. IUBMB Life.\u00a02020;72(7):1449\u201359.\u00a0https:\/\/doi.org\/10.1002\/iub.2272.","DOI":"10.1002\/iub.2272"},{"issue":"2","key":"531_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/biolre\/ioab094","volume":"105","author":"S Yan","year":"2021","unstructured":"Yan S, et al. C1QTNF6 participates in the pathogenesis of PCOS by affecting the inflammatory response of granulosa cells. Biol Reprod. 2021;105(2):427\u201338. https:\/\/doi.org\/10.1093\/biolre\/ioab094.","journal-title":"Biol Reprod"},{"issue":"7","key":"531_CR25","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.3390\/ijms22073789","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka E, et al. Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci. 2021;22(7):3789. https:\/\/doi.org\/10.3390\/ijms22073789.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"531_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0026-0495(99)90100-2","volume":"48","author":"F Gonzalez","year":"1999","unstructured":"Gonzalez F, Thusu K, Abdel-Rahman E, Prabhala A, Tomani M, Dandona P. Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome. Metabolism. 1999;48(4):437\u201341. https:\/\/doi.org\/10.1016\/S0026-0495(99)90100-2.","journal-title":"Metabolism"},{"issue":"3","key":"531_CR27","first-page":"165","volume":"48","author":"NC Sayin","year":"2003","unstructured":"Sayin NC, et al. Elevated serum TNF-alpha levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome. J Reprod Med. 2003;48(3):165\u201370.","journal-title":"J Reprod Med"},{"issue":"6","key":"531_CR28","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0029-7844(03)00233-3","volume":"101","author":"G Amato","year":"2003","unstructured":"Amato G. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol. 2003;101(6):1177\u201382. https:\/\/doi.org\/10.1016\/S0029-7844(03)00233-3.","journal-title":"Obstet Gynecol"},{"issue":"08","key":"531_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1055\/s-2008-1058085","volume":"116","author":"B Knebel","year":"2008","unstructured":"Knebel B, et al. Increased low grade inflammatory serum markers in patients with polycystic ovary syndrome (PCOS) and their relationship to PPAR\u03b3 gene variants. Exp Clin Endocrinol Diabetes. 2008;116(08):481\u20136. https:\/\/doi.org\/10.1055\/s-2008-1058085.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"531_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ejogrb.2006.10.037","volume":"133","author":"M Olszanecka-Glinianowicz","year":"2007","unstructured":"Olszanecka-Glinianowicz M, et al. Is the polycystic ovary syndrome associated with chronic inflammation per se? Eur J Obstet Gynecol Reprod Biol. 2007;133(2):197\u2013202. https:\/\/doi.org\/10.1016\/j.ejogrb.2006.10.037.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"531_CR31","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.metabol.2006.04.002","volume":"55","author":"AN Vgontzas","year":"2006","unstructured":"Vgontzas AN, et al. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea. Metabolism. 2006;55(8):1076\u201382. https:\/\/doi.org\/10.1016\/j.metabol.2006.04.002.","journal-title":"Metabolism"},{"issue":"12","key":"531_CR32","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1902\/jop.2013.120483","volume":"84","author":"\u00d6 \u00d6z\u00e7aka","year":"2013","unstructured":"\u00d6z\u00e7aka \u00d6, et al. Is Interleukin-17 involved in the interaction between polycystic ovary syndrome and gingival inflammation? J Periodontol. 2013;84(12):1827\u201337. https:\/\/doi.org\/10.1902\/jop.2013.120483.","journal-title":"J Periodontol"},{"issue":"6","key":"531_CR33","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1600-0897.2011.01059.x","volume":"66","author":"Y-S Lin","year":"2011","unstructured":"Lin Y-S, Tsai S-J, Lin M-W, Yang C-T, Huang M-F, Wu M-H. Interleukin-6 as an early chronic inflammatory marker in polycystic ovary syndrome with insulin receptor Substrate-2 Polymorphism: IL-6 AS a MARKER IN PCOS WITH IRS-2 POLYMORPHISM. Am J Reprod Immunol. 2011;66(6):527\u201333. https:\/\/doi.org\/10.1111\/j.1600-0897.2011.01059.x.","journal-title":"Am J Reprod Immunol"},{"issue":"6505","key":"531_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/372425a0","volume":"372","author":"Y Zhang","year":"1994","unstructured":"Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425\u201332. https:\/\/doi.org\/10.1038\/372425a0.","journal-title":"Nature"},{"issue":"1","key":"531_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejogrb.2011.07.012","volume":"159","author":"Y Xiong","year":"2011","unstructured":"Xiong Y, Liang X, Yang X, Li Y, Wei L. Low-grade chronic inflammation in the peripheral blood and ovaries of women with polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol. 2011;159(1):148\u201350. https:\/\/doi.org\/10.1016\/j.ejogrb.2011.07.012.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"531_CR36","doi-asserted-by":"publisher","unstructured":"Ghowsi M, Khazali H, Sisakhtnezhad S. Evaluation of Tnf-\u03b1 and Il-6 mRNAs expressions in visceral and subcutaneous adipose tissues of polycystic ovarian rats and effects of resveratrol. Iran J Basic Med Sci. 2018;21(2).\u00a0https:\/\/doi.org\/10.22038\/ijbms.2017.24801.6167.","DOI":"10.22038\/ijbms.2017.24801.6167"},{"issue":"4","key":"531_CR37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1155\/2009\/465203","volume":"26","author":"N Samy","year":"2009","unstructured":"Samy N, Hashim M, Sayed M, Said M. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index. Dis Markers. 2009;26(4):163\u201370. https:\/\/doi.org\/10.1155\/2009\/465203.","journal-title":"Dis Markers"},{"issue":"4","key":"531_CR38","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1172\/JCI117495","volume":"94","author":"GS Hotamisligil","year":"1994","unstructured":"Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest. 1994;94(4):1543\u20139. https:\/\/doi.org\/10.1172\/JCI117495.","journal-title":"J Clin Invest"},{"issue":"3","key":"531_CR39","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00404-020-05951-2","volume":"303","author":"S Abraham Gnanadass","year":"2021","unstructured":"Abraham Gnanadass S, Divakar Prabhu Y, Valsala Gopalakrishnan A. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Arch Gynecol Obstet. 2021;303(3):631\u201343. https:\/\/doi.org\/10.1007\/s00404-020-05951-2.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"531_CR40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nm.2627","volume":"18","author":"O Osborn","year":"2012","unstructured":"Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med. 2012;18(3):363\u201374. https:\/\/doi.org\/10.1038\/nm.2627.","journal-title":"Nat Med"},{"issue":"7","key":"531_CR41","first-page":"58","volume":"16","author":"JR Lundon","year":"1970","unstructured":"Lundon JR. Insulin-some current concepts. Can Fam Physician Med Fam Can. 1970;16(7):58\u201361.","journal-title":"Can Fam Physician Med Fam Can"},{"key":"531_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/719050","volume":"2014","author":"J Rojas","year":"2014","unstructured":"Rojas J, et al. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J Reprod Med. 2014;2014:1\u201317. https:\/\/doi.org\/10.1155\/2014\/719050.","journal-title":"Int J Reprod Med"},{"issue":"6","key":"531_CR43","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981\u20131030. https:\/\/doi.org\/10.1210\/er.2011-1034.","journal-title":"Endocr Rev"},{"issue":"2","key":"531_CR44","doi-asserted-by":"publisher","first-page":"359","DOI":"10.17219\/acem\/59380","volume":"26","author":"S Bednarska","year":"2017","unstructured":"Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: What\u2019s new? Adv Clin Exp Med. 2017;26(2):359\u201367. https:\/\/doi.org\/10.17219\/acem\/59380.","journal-title":"Adv Clin Exp Med"},{"issue":"2","key":"531_CR45","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1210\/jcem.76.2.8432770","volume":"76","author":"P Preziosi","year":"1993","unstructured":"Preziosi P, et al. Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the telecom study. J Clin Endocrinol Metab. 1993;76(2):283\u20137. https:\/\/doi.org\/10.1210\/jcem.76.2.8432770.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"531_CR46","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0015-0282(16)47243-2","volume":"40","author":"RL Barbieri","year":"1983","unstructured":"Barbieri RL, Makris A, Ryan KJ. Effects of insulin on steroidogenesis in cultured porcine ovarian theca. Fertil Steril. 1983;40(2):237\u201341.","journal-title":"Fertil Steril"},{"issue":"5","key":"531_CR47","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/cen.13808","volume":"89","author":"S Shorakae","year":"2018","unstructured":"Shorakae S, et al. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS. Clin Endocrinol. 2018;89(5):628\u201333. https:\/\/doi.org\/10.1111\/cen.13808.","journal-title":"Clin Endocrinol"},{"key":"531_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/9240569","volume":"2022","author":"Y Xu","year":"2022","unstructured":"Xu Y, Qiao J. Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature. J Healthc Eng. 2022;2022:1\u201313. https:\/\/doi.org\/10.1155\/2022\/9240569.","journal-title":"J Healthc Eng"},{"key":"531_CR49","doi-asserted-by":"publisher","first-page":"667422","DOI":"10.3389\/fendo.2021.667422","volume":"12","author":"B Liao","year":"2021","unstructured":"Liao B, Qiao J, Pang Y. Central regulation of PCOS: abnormal neuronal-reproductive-metabolic circuits in PCOS pathophysiology. Front Endocrinol. 2021;12:667422. https:\/\/doi.org\/10.3389\/fendo.2021.667422.","journal-title":"Front Endocrinol"},{"issue":"8","key":"531_CR50","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.3390\/ijms23084110","volume":"23","author":"D Armanini","year":"2022","unstructured":"Armanini D, Boscaro M, Bordin L, Sabbadin C. Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and Hyperandrogenism. Int J Mol Sci. 2022;23(8):4110. https:\/\/doi.org\/10.3390\/ijms23084110.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"531_CR51","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1210\/jc.2005-2327","volume":"91","author":"F Gonz\u00e1lez","year":"2006","unstructured":"Gonz\u00e1lez F, Rote NS, Minium J, Kirwan JP. Increased activation of nuclear factor \u03baB triggers inflammation and insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(4):1508\u201312. https:\/\/doi.org\/10.1210\/jc.2005-2327.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"531_CR52","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1152\/ajpendo.2000.278.1.E1","volume":"278","author":"TJ Kieffer","year":"2000","unstructured":"Kieffer TJ, Habener JF. The adipoinsular axis: effects of leptin on pancreatic \u03b2-cells. Am J Physiol-Endocrinol Metab. 2000;278(1):E1\u2013E14. https:\/\/doi.org\/10.1152\/ajpendo.2000.278.1.E1.","journal-title":"Am J Physiol-Endocrinol Metab"},{"issue":"4155","key":"531_CR53","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.185.4155.949","volume":"185","author":"RE Frisch","year":"1974","unstructured":"Frisch RE, McArthur JW. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science. 1974;185(4155):949\u201351. https:\/\/doi.org\/10.1126\/science.185.4155.949.","journal-title":"Science"},{"key":"531_CR54","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000316895","volume-title":"Endocrine Development","author":"GJ Hausman","year":"2010","unstructured":"Hausman GJ, Barb CR. Adipose tissue and the reproductive Axis: biological aspects. In: Levy-Marchal C, P\u00e9nicaud L, editors. Endocrine Development. S. Karger AG; 2010. p. 31\u201344. https:\/\/doi.org\/10.1159\/000316895."},{"key":"531_CR55","doi-asserted-by":"publisher","unstructured":"P\u00e9rez-P\u00e9rez A, S\u00e1nchez-Jim\u00e9nez F, Maym\u00f3 J, Due\u00f1as JL, Varone C, S\u00e1nchez-Margalet V. Role of leptin in female reproduction. Clin Chem Lab Med CCLM. 2015;53(1).\u00a0https:\/\/doi.org\/10.1515\/cclm-2014-0387.","DOI":"10.1515\/cclm-2014-0387"},{"issue":"3","key":"531_CR56","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/humupd\/dmv057","volume":"22","author":"A Catteau","year":"2016","unstructured":"Catteau A, Caillon H, Barri\u00e8re P, Denis MG, Masson D, Fr\u00e9our T. Leptin and its potential interest in assisted reproduction cycles. Hum Reprod Update. 2016;22(3):320\u201341. https:\/\/doi.org\/10.1093\/humupd\/dmv057.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"531_CR57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ng0996-95","volume":"14","author":"C Vaisse","year":"1996","unstructured":"Vaisse C, Halaas JL, Horvath CM, Darnell JE, Stoffel M, Friedman JM. Leptin activation of Stat3 in the hypothalamus of wild\u2013type and Ob\/Ob mice but not db\/db mice. Nat Genet. 1996;14(1):95\u20137. https:\/\/doi.org\/10.1038\/ng0996-95.","journal-title":"Nat Genet"},{"issue":"2","key":"531_CR58","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0739-7240(96)00119-1","volume":"14","author":"CJ Dyer","year":"1997","unstructured":"Dyer CJ, Simmons JM, Matteri RL, Keisler DH. Leptin receptor mRNA is expressed in ewe anterior pituitary and adipose tissues and is differentially expressed in hypothalamic regions of well-fed and feed-restricted ewes. Domest Anim Endocrinol. 1997;14(2):119\u201328. https:\/\/doi.org\/10.1016\/S0739-7240(96)00119-1.","journal-title":"Domest Anim Endocrinol"},{"issue":"1","key":"531_CR59","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0739-7240(00)00064-3","volume":"19","author":"J Lin","year":"2000","unstructured":"Lin J, et al. Long form leptin receptor mRNA expression in the brain, pituitary, and other tissues in the pig. Domest Anim Endocrinol. 2000;19(1):53\u201361. https:\/\/doi.org\/10.1016\/S0739-7240(00)00064-3.","journal-title":"Domest Anim Endocrinol"},{"issue":"3","key":"531_CR60","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000127232","volume":"66","author":"ME Couce","year":"1997","unstructured":"Couce ME, Burguera B, Parisi JE, Jensen MD, Lloyd RV. Localization of leptin receptor in the human brain. Neuroendocrinology. 1997;66(3):145\u201350. https:\/\/doi.org\/10.1159\/000127232.","journal-title":"Neuroendocrinology"},{"issue":"14","key":"531_CR61","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1097\/00001756-199709290-00023","volume":"8","author":"A Savioz","year":"1997","unstructured":"Savioz A, Charnay Y, Huguenin C, Graviou C, Greggio B, Bouras C. Expression of leptin receptor mRNA (long form splice variant) in the human cerebellum. NeuroReport. 1997;8(14):3123\u20136. https:\/\/doi.org\/10.1097\/00001756-199709290-00023.","journal-title":"NeuroReport"},{"issue":"6549","key":"531_CR62","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/377530a0","volume":"377","author":"TW Stephens","year":"1995","unstructured":"Stephens TW, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 1995;377(6549):530\u20132. https:\/\/doi.org\/10.1038\/377530a0.","journal-title":"Nature"},{"issue":"5","key":"531_CR63","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00018-012-1095-1","volume":"70","author":"CF Elias","year":"2013","unstructured":"Elias CF, Purohit D. Leptin signaling and circuits in puberty and fertility. Cell Mol Life Sci. 2013;70(5):841\u201362. https:\/\/doi.org\/10.1007\/s00018-012-1095-1.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"531_CR64","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/humrep\/15.3.539","volume":"15","author":"CS Mantzoros","year":"2000","unstructured":"Mantzoros CS, Cramer DW, Liberman RF, Barbieri RL. Predictive value of serum and follicular fluid leptin concentrations during assisted reproductive cycles in normal women and in women with the polycystic ovarian syndrome. Hum Reprod. 2000;15(3):539\u201344. https:\/\/doi.org\/10.1093\/humrep\/15.3.539.","journal-title":"Hum Reprod"},{"issue":"2","key":"531_CR65","doi-asserted-by":"publisher","first-page":"e57972","DOI":"10.1371\/journal.pone.0057972","volume":"8","author":"J-AP De Bond","year":"2013","unstructured":"De Bond J-AP, Li Q, Millar RP, Clarke IJ, Smith JT. Kisspeptin signaling is required for the luteinizing hormone response in anestrous ewes following the introduction of males. PLoS One. 2013;8(2):e57972. https:\/\/doi.org\/10.1371\/journal.pone.0057972.","journal-title":"PLoS One"},{"key":"531_CR66","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3389\/fendo.2019.00298","volume":"10","author":"R Tang","year":"2019","unstructured":"Tang R, Ding X, Zhu J. Kisspeptin and polycystic ovary syndrome. Front Endocrinol. 2019;10:298. https:\/\/doi.org\/10.3389\/fendo.2019.00298.","journal-title":"Front Endocrinol"},{"issue":"3","key":"531_CR67","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1073\/pnas.94.3.1023","volume":"94","author":"WH Yu","year":"1997","unstructured":"Yu WH, Kimura M, Walczewska A, Karanth S, McCann SM. Role of leptin in hypothalamic\u2013pituitary function. Proc Natl Acad Sci. 1997;94(3):1023\u20138. https:\/\/doi.org\/10.1073\/pnas.94.3.1023.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"531_CR68","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1677\/joe.0.1680067","volume":"168","author":"B Henry","year":"2001","unstructured":"Henry B, Goding J, Tilbrook A, Dunshea F, Clarke I. Intracerebroventricular infusion of leptin elevates the secretion of luteinising hormone without affecting food intake in long-term food-restricted sheep, but increases growth hormone irrespective of bodyweight. J Endocrinol. 2001;168(1):67\u201377. https:\/\/doi.org\/10.1677\/joe.0.1680067.","journal-title":"J Endocrinol"},{"issue":"2","key":"531_CR69","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1677\/joe.0.1680317","volume":"168","author":"C Morrison","year":"2001","unstructured":"Morrison C, et al. Central infusion of leptin into well-fed and undernourished ewe lambs: effects on feed intake and serum concentrations of growth hormone and luteinizing hormone. J Endocrinol. 2001;168(2):317\u201324. https:\/\/doi.org\/10.1677\/joe.0.1680317.","journal-title":"J Endocrinol"},{"issue":"7","key":"531_CR70","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/sj.ijo.0800902","volume":"23","author":"E Demerath","year":"1999","unstructured":"Demerath E, Towne B, Wisemandle W, Blangero J, Cameron Chumlea W, Siervogel M. Serum leptin concentration, body composition, and gonadal hormones during puberty. Int J Obes. 1999;23(7):678\u201385. https:\/\/doi.org\/10.1038\/sj.ijo.0800902.","journal-title":"Int J Obes"},{"issue":"2","key":"531_CR71","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4103\/2141-9248.113660","volume":"3","author":"J Chakrabarti","year":"2013","unstructured":"Chakrabarti J. Serum leptin level in women with polycystic ovary syndrome: correlation with adiposity, insulin, and circulating testosterone. Ann Med Health Sci Res. 2013;3(2):191. https:\/\/doi.org\/10.4103\/2141-9248.113660.","journal-title":"Ann Med Health Sci Res"},{"issue":"1","key":"531_CR72","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0739-7240(00)00088-6","volume":"20","author":"CR Barb","year":"2001","unstructured":"Barb CR, Barrett JB, Kraeling RR, Rampacek GB. Serum leptin concentrations, luteinizing hormone and growth hormone secretion during feed and metabolic fuel restriction in the prepuberal gilt. Domest Anim Endocrinol. 2001;20(1):47\u201363. https:\/\/doi.org\/10.1016\/S0739-7240(00)00088-6.","journal-title":"Domest Anim Endocrinol"},{"issue":"6","key":"531_CR73","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1172\/JCI118007","volume":"95","author":"RV Considine","year":"1995","unstructured":"Considine RV, et al. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest. 1995;95(6):2986\u20138. https:\/\/doi.org\/10.1172\/JCI118007.","journal-title":"J Clin Invest"},{"issue":"11","key":"531_CR74","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/nm1195-1155","volume":"1","author":"M Maffei","year":"1995","unstructured":"Maffei M, et al. Leptin levels in human and rodent: measurement of plasma leptin and Ob RNA in obese and weight-reduced subjects. Nat Med. 1995;1(11):1155\u201361. https:\/\/doi.org\/10.1038\/nm1195-1155.","journal-title":"Nat Med"},{"issue":"3","key":"531_CR75","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.physbeh.2006.05.038","volume":"88","author":"Y Zhang","year":"2006","unstructured":"Zhang Y, Scarpace PJ. The role of leptin in leptin resistance and obesity. Physiol Behav. 2006;88(3):249\u201356. https:\/\/doi.org\/10.1016\/j.physbeh.2006.05.038.","journal-title":"Physiol Behav"},{"issue":"12","key":"531_CR76","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1056\/NEJM199909163411204","volume":"341","author":"IS Farooqi","year":"1999","unstructured":"Farooqi IS, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med. 1999;341(12):879\u201384. https:\/\/doi.org\/10.1056\/NEJM199909163411204.","journal-title":"N Engl J Med"},{"key":"531_CR77","doi-asserted-by":"publisher","unstructured":"\u2022 Di Lorenzo M, et al. Pathophysiology and nutritional approaches in polycystic ovary syndrome (PCOS): a comprehensive review. Curr Nutr Rep. 2023; https:\/\/doi.org\/10.1007\/s13668-023-00479-8. This very recent review describes the main aspects of the physiolatology of PCOS and aims to gather evidence on different nutritional approaches, such as the Mediterranean diet and ketogenic diet, as well as bariatric surgery and nutraceutical supplementation used in patients with PCOS.","DOI":"10.1007\/s13668-023-00479-8"},{"issue":"8","key":"531_CR78","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1590\/S0004-27302011000800013","volume":"55","author":"PM Merino","year":"2011","unstructured":"Merino PM, Codner E, Cassorla F. A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence. Arq Bras Endocrinol Metabol. 2011;55(8):590\u20138. https:\/\/doi.org\/10.1590\/S0004-27302011000800013.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"20","key":"531_CR79","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.3390\/cells11203255","volume":"11","author":"E Carmina","year":"2022","unstructured":"Carmina E, Longo RA. Increased prevalence of elevated DHEAS in PCOS women with non-classic (B or C) phenotypes: a retrospective analysis in patients aged 20 to 29 years. Cells. 2022;11(20):3255. https:\/\/doi.org\/10.3390\/cells11203255.","journal-title":"Cells"},{"issue":"4","key":"531_CR80","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5455\/medarh.2020.74.289-293","volume":"74","author":"Z Saadia","year":"2020","unstructured":"Saadia Z. Follicle stimulating hormone (LH: FSH) ratio in polycystic ovary syndrome (PCOS) - obese vs. non- obese women. Med Arch. 2020;74(4):289. https:\/\/doi.org\/10.5455\/medarh.2020.74.289-293.","journal-title":"Med Arch"},{"issue":"1","key":"531_CR81","doi-asserted-by":"publisher","first-page":"59.e1","DOI":"10.1016\/j.ajog.2014.02.026","volume":"211","author":"R Tal","year":"2014","unstructured":"Tal R, Seifer DB, Khanimov M, Malter HE, Grazi RV, Leader B. Characterization of women with elevated antim\u00fcllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes. Am J Obstet Gynecol. 2014;211(1):59.e1\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2014.02.026.","journal-title":"Am J Obstet Gynecol"},{"key":"531_CR82","doi-asserted-by":"publisher","unstructured":"Davoudi Z, Araghi F, Vahedi M, Mokhtari N, Gheisari M. Prolactin level in polycystic ovary syndrome (PCOS): an approach to the diagnosis and management. Acta Biomed Atenei Parm. 2021;92(5):e2021291.\u00a0https:\/\/doi.org\/10.23750\/abm.v92i5.9866.","DOI":"10.23750\/abm.v92i5.9866"},{"issue":"1","key":"531_CR83","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12958-022-01005-1","volume":"20","author":"S Xu","year":"2022","unstructured":"Xu S, Zhang Y, Qiang C, Zhang C. Effect of TSH on oocyte maturation of PCOS patients with normal thyroid function in IVF. Reprod Biol Endocrinol. 2022;20(1):133. https:\/\/doi.org\/10.1186\/s12958-022-01005-1.","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"531_CR84","doi-asserted-by":"publisher","first-page":"e3682","DOI":"10.1002\/dmrr.3682","volume":"39","author":"IG Lempesis","year":"2023","unstructured":"Lempesis IG, et al. Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndrome. Diabetes Metab Res Rev. 2023;39(6):e3682. https:\/\/doi.org\/10.1002\/dmrr.3682.","journal-title":"Diabetes Metab Res Rev"},{"key":"531_CR85","doi-asserted-by":"publisher","unstructured":"Teede HJ, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023:dgad463. https:\/\/doi.org\/10.1210\/clinem\/dgad463.","DOI":"10.1210\/clinem\/dgad463"},{"issue":"3","key":"531_CR86","doi-asserted-by":"publisher","first-page":"613","DOI":"10.5114\/aoms.2019.82672","volume":"15","author":"KC Lewandowski","year":"2019","unstructured":"Lewandowski KC, et al. How much insulin resistance in polycystic ovary syndrome? Comparison of HOMA-IR and insulin resistance (Belfiore) index models. Arch Med Sci. 2019;15(3):613\u20138. https:\/\/doi.org\/10.5114\/aoms.2019.82672.","journal-title":"Arch Med Sci"},{"key":"531_CR87","doi-asserted-by":"publisher","first-page":"117955811986193","DOI":"10.1177\/1179558119861936","volume":"13","author":"Z Blumenfeld","year":"2019","unstructured":"Blumenfeld Z. The possible practical implication of high CRP levels in PCOS. Clin Med Insights Reprod Health. 2019;13:117955811986193. https:\/\/doi.org\/10.1177\/1179558119861936.","journal-title":"Clin Med Insights Reprod Health"},{"issue":"9","key":"531_CR88","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1089\/gtmb.2014.0151","volume":"18","author":"S Thathapudi","year":"2014","unstructured":"Thathapudi S, Kodati V, Erukkambattu J, Katragadda A, Addepally U, Hasan Q. Tumor necrosis factor-alpha and polycystic ovarian syndrome: a clinical, biochemical, and molecular genetic study. Genet Test Mol Biomark. 2014;18(9):605\u20139. https:\/\/doi.org\/10.1089\/gtmb.2014.0151.","journal-title":"Genet Test Mol Biomark"},{"issue":"10","key":"531_CR89","doi-asserted-by":"publisher","first-page":"e10811","DOI":"10.7759\/cureus.10811","volume":"12","author":"R Lee","year":"2020","unstructured":"Lee R, Joy Mathew C, Jose MT, Elshaikh AO, Shah L, Cancarevic I. A review of the impact of bariatric surgery in women with polycystic ovary syndrome. Cureus. 2020;12(10):e10811. https:\/\/doi.org\/10.7759\/cureus.10811.","journal-title":"Cureus"},{"key":"531_CR90","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","volume":"182","author":"S Patel","year":"2018","unstructured":"Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27\u201336. https:\/\/doi.org\/10.1016\/j.jsbmb.2018.04.008.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"531_CR91","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2478\/enr-2022-0008","volume":"56","author":"V Melo","year":"2022","unstructured":"\u2022\u2022 Melo V, et al. Omega-3 supplementation in the treatment of polycystic ovary syndrome (PCOS) \u2013 a review of clinical trials and cohort. Endocr Regul. 2022;56(1):66\u201379. https:\/\/doi.org\/10.2478\/enr-2022-0008. Systematic review of clinical trials and cohort of the MEDLINE\/PubMed database from 2009 to October 2019. Omega-3 supplementation improved and regulated the glycemic, lipid and androgenic profiles and modulated the inflammatory pattern in women with PCOS.","journal-title":"Endocr Regul"},{"issue":"8","key":"531_CR92","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s43032-021-00826-6","volume":"29","author":"S Shojaei-Zarghani","year":"2022","unstructured":"Shojaei-Zarghani S, Molani-Gol R, Rafraf M. Curcumin and polycystic ovary syndrome: a systematic review. Reprod Sci. 2022;29(8):2105\u201318. https:\/\/doi.org\/10.1007\/s43032-021-00826-6.","journal-title":"Reprod Sci"},{"issue":"9","key":"531_CR93","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/1440-1681.13698","volume":"49","author":"A Karimi","year":"2022","unstructured":"\u2022 Karimi A, Tutunchi H, Naeini F, Vajdi M, Mobasseri M, Najafipour F. The therapeutic effects and mechanisms of action of resveratrol on polycystic ovary syndrome: a comprehensive systematic review of clinical, animal and in vitro studies. Clin Exp Pharmacol Physiol. 2022;49(9):935\u201349. https:\/\/doi.org\/10.1111\/1440-1681.13698. Resveratrol supplementation might be effective in improving PCOS-related symptoms by reducing insulin resistance, alleviating dyslipidemia, improving ovarian morphology and anthropometric indices, regulating the reproductive hormones and reducing inflammation and oxidative stress.bara.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"531_CR94","doi-asserted-by":"publisher","unstructured":"Zhou Y, Lan H, Dong Z, Cao W, Zeng Z, Song J. Dietary proanthocyanidins alleviated ovarian fibrosis in letrozole-induced polycystic ovary syndrome in rats. J Food Biochem. 2021;45(5) https:\/\/doi.org\/10.1111\/jfbc.13723.","DOI":"10.1111\/jfbc.13723"},{"issue":"4","key":"531_CR95","doi-asserted-by":"publisher","first-page":"E744","DOI":"10.1152\/ajpendo.00228.2020","volume":"319","author":"F Gonz\u00e1lez","year":"2020","unstructured":"Gonz\u00e1lez F, Mather KJ, Considine RV, Abdelhadi OA, Acton AJ. Salicylate administration suppresses the inflammatory response to nutrients and improves ovarian function in polycystic ovary syndrome. Am J Physiol-Endocrinol Metab. 2020;319(4):E744\u201352. https:\/\/doi.org\/10.1152\/ajpendo.00228.2020.","journal-title":"Am J Physiol-Endocrinol Metab"},{"issue":"4","key":"531_CR96","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/17512433.2017.1292125","volume":"10","author":"EM Lamos","year":"2017","unstructured":"Lamos EM, Malek R, Davis SN. GLP-1 receptor agonists in the treatment of polycystic ovary syndrome. Expert Rev Clin Pharmacol. 2017;10(4):401\u20138. https:\/\/doi.org\/10.1080\/17512433.2017.1292125.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"2","key":"531_CR97","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.rbmo.2019.04.017","volume":"39","author":"Y Han","year":"2019","unstructured":"Han Y, Li Y, He B. GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis. Reprod BioMed Online. 2019;39(2):332\u201342. https:\/\/doi.org\/10.1016\/j.rbmo.2019.04.017.","journal-title":"Reprod BioMed Online"},{"issue":"1","key":"531_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-18-0175","volume":"179","author":"V Salamun","year":"2018","unstructured":"Salamun V, Jensterle M, Janez A, Vrtacnik Bokal E. Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study. Eur J Endocrinol. 2018;179(1):1\u201311. https:\/\/doi.org\/10.1530\/EJE-18-0175.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"531_CR99","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/cen.13454","volume":"87","author":"X Liu","year":"2017","unstructured":"Liu X, et al. Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight\/obese polycystic ovary syndrome. Clin Endocrinol. 2017;87(6):767\u201374. https:\/\/doi.org\/10.1111\/cen.13454.","journal-title":"Clin Endocrinol"},{"key":"531_CR100","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ebiom.2017.05.028","volume":"20","author":"L Xu","year":"2017","unstructured":"Xu L, et al. SGLT2 inhibition by Empagliflozin promotes fat utilization and browning and attenuates inflammation and insulin resistance by polarizing M2 macrophages in diet-induced obese mice. EBioMedicine. 2017;20:137\u201349. https:\/\/doi.org\/10.1016\/j.ebiom.2017.05.028.","journal-title":"EBioMedicine"},{"issue":"5","key":"531_CR101","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.3390\/ijms22052576","volume":"22","author":"JE Pruett","year":"2021","unstructured":"Pruett JE, et al. Impact of SGLT-2 inhibition on cardiometabolic abnormalities in a rat model of polycystic ovary syndrome. Int J Mol Sci. 2021;22(5):2576. https:\/\/doi.org\/10.3390\/ijms22052576.","journal-title":"Int J Mol Sci"},{"key":"531_CR102","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/B978-0-12-813148-0.00014-1","volume-title":"The role of functional food security in Global Health","author":"H Chaves","year":"2019","unstructured":"Chaves H, Singh RB, Khan S, Wilczynska A, Takahashi T. High Omega-6\/Omega-3 fatty acid ratio diets and risk of noncommunicable diseases. In: The role of functional food security in Global Health. Elsevier; 2019. p. 217\u201359. https:\/\/doi.org\/10.1016\/B978-0-12-813148-0.00014-1."},{"key":"531_CR103","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/B978-0-12-407849-9.00016-6","volume-title":"The Mediterranean diet","author":"E Prato","year":"2015","unstructured":"Prato E, Biandolino F. The contribution of fish to the Mediterranean diet. In: The Mediterranean diet. Elsevier; 2015. p. 165\u201374. https:\/\/doi.org\/10.1016\/B978-0-12-407849-9.00016-6."},{"key":"531_CR104","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mce.2015.04.025","volume":"412","author":"L Cheng","year":"2015","unstructured":"Cheng L, Yu Y, Zhang Q, Szabo A, Wang H, Huang X-F. Arachidonic acid impairs hypothalamic leptin signaling and hepatic energy homeostasis in mice. Mol Cell Endocrinol. 2015;412:12\u20138. https:\/\/doi.org\/10.1016\/j.mce.2015.04.025.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"531_CR105","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1210\/en.2007-1307","volume":"149","author":"AS Metlakunta","year":"2008","unstructured":"Metlakunta AS, Sahu M, Sahu A. Hypothalamic phosphatidylinositol 3-kinase pathway of leptin signaling is impaired during the development of diet-induced obesity in FVB\/N mice. Endocrinology. 2008;149(3):1121\u20138. https:\/\/doi.org\/10.1210\/en.2007-1307.","journal-title":"Endocrinology"},{"issue":"3","key":"531_CR106","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/nu8030128","volume":"8","author":"A Simopoulos","year":"2016","unstructured":"Simopoulos A. An increase in the Omega-6\/Omega-3 fatty acid ratio increases the risk for obesity. Nutrients. 2016;8(3):128. https:\/\/doi.org\/10.3390\/nu8030128.","journal-title":"Nutrients"},{"issue":"5","key":"531_CR107","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.0954-6820.1980.tb01221.x","volume":"208","author":"N Kromann","year":"1980","unstructured":"Kromann N, Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand. 1980;208(5):401\u20136.","journal-title":"Acta Med Scand"},{"issue":"12","key":"531_CR108","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.2337\/diacare.17.12.1498","volume":"17","author":"AI Adler","year":"1994","unstructured":"Adler AI, Boyko EJ, Schraer CD, Murphy NJ. Lower prevalence of impaired glucose tolerance and diabetes associated with daily seal oil or Salmon consumption among Alaska natives. Diabetes Care. 1994;17(12):1498\u2013501. https:\/\/doi.org\/10.2337\/diacare.17.12.1498.","journal-title":"Diabetes Care"},{"issue":"4","key":"531_CR109","first-page":"272","volume":"58","author":"CD Schraer","year":"1999","unstructured":"Schraer CD, Risica PM, Ebbesson SO, Go OT, Howard BV, Mayer AM. Low fasting insulin levels in Eskimos compared to American Indians: are Eskimos less insulin resistant? Int J Circumpolar Health. 1999;58(4):272\u201380.","journal-title":"Int J Circumpolar Health"},{"issue":"6","key":"531_CR110","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/ajcn\/86.5.1670","volume":"86","author":"M Kabir","year":"2007","unstructured":"Kabir M, et al. Treatment for 2 mo with n\u22123 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr. 2007;86(6):1670\u20139. https:\/\/doi.org\/10.1093\/ajcn\/86.5.1670.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"531_CR111","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3945\/ajcn.110.005538","volume":"93","author":"N Phelan","year":"2011","unstructured":"Phelan N, et al. Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial. Am J Clin Nutr. 2011;93(3):652\u201362. https:\/\/doi.org\/10.3945\/ajcn.110.005538.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"531_CR112","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3390\/ijms22010384","volume":"22","author":"P-A Regidor","year":"2020","unstructured":"Regidor P-A, Mueller A, Sailer M, Gonzalez Santos F, Rizo JM, Moreno Egea F. Chronic inflammation in PCOS: the potential benefits of specialized pro-resolving lipid mediators (SPMs) in the improvement of the resolutive response. Int J Mol Sci. 2020;22(1):384. https:\/\/doi.org\/10.3390\/ijms22010384.","journal-title":"Int J Mol Sci"},{"issue":"16","key":"531_CR113","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1080\/10408398.2015.1126549","volume":"57","author":"E Tortosa-Caparr\u00f3s","year":"2017","unstructured":"Tortosa-Caparr\u00f3s E, Navas-Carrillo D, Mar\u00edn F, Orenes-Pi\u00f1ero E. Anti-inflammatory effects of omega 3 and omega 6 polyunsaturated fatty acids in cardiovascular disease and metabolic syndrome. Crit Rev Food Sci Nutr. 2017;57(16):3421\u20139. https:\/\/doi.org\/10.1080\/10408398.2015.1126549.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"10","key":"531_CR114","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/S0022-2275(20)37127-3","volume":"38","author":"T Raclot","year":"1997","unstructured":"Raclot T, Groscolas R, Langin D, Ferr\u00e9 P. Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues. J Lipid Res. 1997;38(10):1963\u201372.","journal-title":"J Lipid Res"},{"issue":"5","key":"531_CR115","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0022-2275(20)31636-9","volume":"42","author":"JE Reseland","year":"2001","unstructured":"Reseland JE, et al. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res. 2001;42(5):743\u201350.","journal-title":"J Lipid Res"},{"issue":"1","key":"531_CR116","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1743-7075-8-31","volume":"8","author":"C Fan","year":"2011","unstructured":"Fan C, Liu X, Shen W, Deckelbaum RJ, Qi K. The regulation of leptin, leptin receptor and pro-opiomelanocortin expression by N-3 PUFAs in diet-induced obese mice is not related to the methylation of their promoters. Nutr Metab. 2011;8(1):31. https:\/\/doi.org\/10.1186\/1743-7075-8-31.","journal-title":"Nutr Metab"},{"issue":"8","key":"531_CR117","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/09513590.2022.2089106","volume":"38","author":"D Menichini","year":"2022","unstructured":"\u2022\u2022 Menichini D, Ughetti C, Monari F, Di Vinci PL, Neri I, Facchinetti F. Nutraceuticals and polycystic ovary syndrome: a systematic review of the literature. Gynecol Endocrinol. 2022;38(8):623\u201331. https:\/\/doi.org\/10.1080\/09513590.2022.2089106. Supplementation with inositol improves glucose homeostasis and fertility in PCOS. Combinations of vitamin D and probiotics, vitamin E and coenzyme Q10 reduced hyperandrogenism. Co-supplementation of probiotics and selenium or of vitamin E with omega 3 improved the inflammatory status and antioxidant capacity in PCOS.","journal-title":"Gynecol Endocrinol"},{"key":"531_CR118","doi-asserted-by":"publisher","first-page":"183","DOI":"10.15403\/jgld-179","volume":"28","author":"SR Mirhafez","year":"2019","unstructured":"Mirhafez SR, et al. Effect of Phytosomal curcumin on circulating levels of adiponectin and leptin in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled clinical trial. J Gastrointestin Liver Dis. 2019;28:183\u20139. https:\/\/doi.org\/10.15403\/jgld-179.","journal-title":"J Gastrointestin Liver Dis"},{"key":"531_CR119","doi-asserted-by":"publisher","first-page":"108561","DOI":"10.1016\/j.jnutbio.2020.108561","volume":"89","author":"S Montserrat-de La Paz","year":"2021","unstructured":"\u2022 Montserrat-de La Paz S, et al. Nutritional modulation of leptin expression and leptin action in obesity and obesity-associated complications. J Nutr Biochem. 2021;89:108561. https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108561. Obesity is associated with hyperleptinemia and leptin resistance, that can be related to chronic inflammatory state and infertility. Phenols, peptides, and vitamins might modulate leptin metabolism and decrease inflammation, ameliorating infertility clinical pictures.","journal-title":"J Nutr Biochem"},{"issue":"1","key":"531_CR120","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ijo.2016.169","volume":"41","author":"M Ibars","year":"2017","unstructured":"Ibars M, Ardid-Ruiz A, Su\u00e1rez M, Muguerza B, Blad\u00e9 C, Aragon\u00e8s G. Proanthocyanidins potentiate hypothalamic leptin\/STAT3 signalling and Pomc gene expression in rats with diet-induced obesity. Int J Obes. 2017;41(1):129\u201336. https:\/\/doi.org\/10.1038\/ijo.2016.169.","journal-title":"Int J Obes"},{"issue":"2","key":"531_CR121","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00394-015-0880-7","volume":"55","author":"JG Franco","year":"2016","unstructured":"Franco JG, et al. Resveratrol treatment rescues hyperleptinemia and improves hypothalamic leptin signaling programmed by maternal high-fat diet in rats. Eur J Nutr. 2016;55(2):601\u201310. https:\/\/doi.org\/10.1007\/s00394-015-0880-7.","journal-title":"Eur J Nutr"},{"issue":"11","key":"531_CR122","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.3390\/nu10111757","volume":"10","author":"A Ardid-Ruiz","year":"2018","unstructured":"Ardid-Ruiz A, et al. Potential involvement of peripheral leptin\/STAT3 signaling in the effects of resveratrol and its metabolites on reducing body fat accumulation. Nutrients. 2018;10(11):1757. https:\/\/doi.org\/10.3390\/nu10111757.","journal-title":"Nutrients"},{"issue":"4","key":"531_CR123","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12263-015-0469-z","volume":"10","author":"EF Hoek-van Den Hil","year":"2015","unstructured":"Hoek-van Den Hil EF, et al. Direct comparison of metabolic health effects of the flavonoids quercetin, hesperetin, epicatechin, apigenin and anthocyanins in high-fat-diet-fed mice. Genes Nutr. 2015;10(4):23. https:\/\/doi.org\/10.1007\/s12263-015-0469-z.","journal-title":"Genes Nutr"},{"issue":"12","key":"531_CR124","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.lfs.2005.07.029","volume":"78","author":"HF Al-Azzawie","year":"2006","unstructured":"Al-Azzawie HF, Alhamdani M-SS. Hypoglycemic and antioxidant effect of oleuropein in alloxan-diabetic rabbits. Life Sci. 2006;78(12):1371\u20137. https:\/\/doi.org\/10.1016\/j.lfs.2005.07.029.","journal-title":"Life Sci"},{"issue":"645","key":"531_CR125","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3399\/bjgp16X684433","volume":"66","author":"A Davis","year":"2016","unstructured":"Davis A, Robson J. The dangers of NSAIDs: look both ways. Br J Gen Pract. 2016;66(645):172\u20133. https:\/\/doi.org\/10.3399\/bjgp16X684433.","journal-title":"Br J Gen Pract"},{"issue":"10","key":"531_CR126","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1210\/jc.2007-2109","volume":"93","author":"CW Chia","year":"2008","unstructured":"Chia CW, Egan JM. Incretin-based therapies in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2008;93(10):3703\u201316. https:\/\/doi.org\/10.1210\/jc.2007-2109.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"531_CR127","doi-asserted-by":"publisher","first-page":"T31","DOI":"10.1530\/JOE-13-0221","volume":"221","author":"C H\u00f6lscher","year":"2014","unstructured":"H\u00f6lscher C. Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases. J Endocrinol. 2014;221(1):T31\u201341. https:\/\/doi.org\/10.1530\/JOE-13-0221.","journal-title":"J Endocrinol"},{"issue":"3","key":"531_CR128","doi-asserted-by":"publisher","first-page":"627","DOI":"10.5603\/EP.a2022.0047","volume":"73","author":"A Baranowska-Bik","year":"2022","unstructured":"\u2022\u2022 Baranowska-Bik A. Therapy of obesity in women with PCOS using GLP-1 analogues \u2014 benefits and limitations [Terapia oty\u0142o\u015bci u kobiet z PCOS przy zastosowaniu analog\u00f3w GLP-1 \u2014 korzy\u015bci i ograniczenia]. Endokrynol Pol. 2022;73(3):627\u201343. https:\/\/doi.org\/10.5603\/EP.a2022.0047. Glucagon-like peptide 1 (GLP-1) analogues treatment in overweight\/obese patients with PCOS reduced the body weight, improved insulin resistance and decreased hyperandrogenaemia.","journal-title":"Endokrynol Pol"},{"key":"531_CR129","doi-asserted-by":"publisher","unstructured":"Yaribeygi H, Sathyapalan T, Sahebkar A. Molecular mechanisms by which GLP-1 RA and DPP-4i induce insulin sensitivity. Life Sci. 2019;234:116776.\u00a0https:\/\/doi.org\/10.1016\/j.lfs.2019.116776.","DOI":"10.1016\/j.lfs.2019.116776"},{"issue":"4","key":"531_CR130","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/biomedicines11040998","volume":"11","author":"D Rakic","year":"2023","unstructured":"Rakic D, et al. The potential of SGLT-2 inhibitors in the treatment of polycystic ovary syndrome: the current status and future perspectives. Biomedicines. 2023;11(4):998. https:\/\/doi.org\/10.3390\/biomedicines11040998.","journal-title":"Biomedicines"}],"container-title":["Current Obesity Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-023-00531-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13679-023-00531-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-023-00531-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T18:18:23Z","timestamp":1710526703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13679-023-00531-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":130,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["531"],"URL":"https:\/\/doi.org\/10.1007\/s13679-023-00531-2","relation":{},"ISSN":["2162-4968"],"issn-type":[{"value":"2162-4968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"27 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}